메뉴 건너뛰기




Volumn 31, Issue 6, 2008, Pages 578-581

Graves' hyperthyroidism of recent onset and Graves' orbitopathy: To ablate or not to ablate the thyroid?

Author keywords

Antithyroid drugs; Graves' disease; Graves' orbitopathy; Intravenous glucocorticoids; Radioiodine therapy; Total thyroid ablation

Indexed keywords

ANTITHYROID AGENT; GLUCOCORTICOID; IODINE 131; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY;

EID: 48449102252     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346411     Document Type: Article
Times cited : (11)

References (31)
  • 1
    • 0034454231 scopus 로고    scopus 로고
    • Management of Graves' ophthalmopathy: Reality and perspectives
    • Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 2000, 21: 168-99.
    • (2000) Endocr Rev , vol.21 , pp. 168-199
    • Bartalena, L.1    Pinchera, A.2    Marcocci, C.3
  • 3
    • 0036930665 scopus 로고    scopus 로고
    • Thyroid acropachy: Report of 40 patients treated at a single institution in a 26-year period
    • Fatourechi V, Ahmed DDF, Schwartz KM. Thyroid acropachy: report of 40 patients treated at a single institution in a 26-year period. J Clin Endocrinol Metab 2002, 87: 5435-41.
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 5435-5441
    • Fatourechi, V.1    Ahmed, D.D.F.2    Schwartz, K.M.3
  • 7
    • 34249854620 scopus 로고    scopus 로고
    • B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: A controlled pilot study
    • El Fassi D, Nielsen CH, Bonnema SJ, Hasselbach HC, Hegedüs L. B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study. J Clin Endocrinol Metab 2007, 92: 1769-72.
    • (2007) J Clin Endocrinol Metab , vol.92 , pp. 1769-1772
    • El Fassi, D.1    Nielsen, C.H.2    Bonnema, S.J.3    Hasselbach, H.C.4    Hegedüs, L.5
  • 8
    • 33847727902 scopus 로고    scopus 로고
    • Treatment of Graves' disease and associated ophthalmopathy wish the anti-CD20 monoclonal antibody rituximab: An open study
    • Salvi M, Vannucchi G, Campi I, et al. Treatment of Graves' disease and associated ophthalmopathy wish the anti-CD20 monoclonal antibody rituximab: an open study. Eur J Endocrinol 2007, 156: 33-40.
    • (2007) Eur J Endocrinol , vol.156 , pp. 33-40
    • Salvi, M.1    Vannucchi, G.2    Campi, I.3
  • 10
    • 33845972971 scopus 로고    scopus 로고
    • Remission of Graves' disease during anti-thyroid drug therapy. Time to reconsider the mechanism?
    • Laurberg P. Remission of Graves' disease during anti-thyroid drug therapy. Time to reconsider the mechanism? Eur J Endocrinol 2006, 155: 783-6.
    • (2006) Eur J Endocrinol , vol.155 , pp. 783-786
    • Laurberg, P.1
  • 11
    • 19744374699 scopus 로고    scopus 로고
    • Effect of long-term continuous methimazole treatment of hyperthyroidism: Comparison with radioiodine
    • Azizi F, Ataie L, Hedayati M, Mehrabi Y, Sheikholeslami F. Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine. Eur J Endocrinol 2005, 152: 695-701.
    • (2005) Eur J Endocrinol , vol.152 , pp. 695-701
    • Azizi, F.1    Ataie, L.2    Hedayati, M.3    Mehrabi, Y.4    Sheikholeslami, F.5
  • 12
    • 0020661086 scopus 로고
    • T-lymphocyte sensitization and suppressor T-lymphocyte defect in patients long after treatment for Graves' disease
    • How J, Topliss DJ, Strakosch G, Lewis M, Row VV, Volpé R. T-lymphocyte sensitization and suppressor T-lymphocyte defect in patients long after treatment for Graves' disease. Clin Endocrinol (Oxf) 1983, 18: 61-71.
    • (1983) Clin Endocrinol (Oxf) , vol.18 , pp. 61-71
    • How, J.1    Topliss, D.J.2    Strakosch, G.3    Lewis, M.4    Row, V.V.5    Volpé, R.6
  • 13
    • 1942425300 scopus 로고    scopus 로고
    • Autoimmune thyroid disease
    • Braverman LE ed, 2nd ed, Totowa USA, Humana Press Inc
    • Mariotti S, Pinna G. Autoimmune thyroid disease. In Braverman LE ed. Diseases of the Thyroid, 2nd ed., Totowa (USA): Humana Press Inc 2003, 107-60.
    • (2003) Diseases of the Thyroid , pp. 107-160
    • Mariotti, S.1    Pinna, G.2
  • 14
    • 0034718938 scopus 로고    scopus 로고
    • Weetman AP. Graves' disease. N Engl J Med 2000, 343: 1236-48.
    • Weetman AP. Graves' disease. N Engl J Med 2000, 343: 1236-48.
  • 15
    • 0032902454 scopus 로고    scopus 로고
    • Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease
    • Costagliola S, Morgenthaler NG, Hoermann R, et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 1999, 84: 90-7.
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 90-97
    • Costagliola, S.1    Morgenthaler, N.G.2    Hoermann, R.3
  • 16
    • 0030829438 scopus 로고    scopus 로고
    • Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment
    • Vitti P, Rago T, Chiovato L, et al. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid 1997, 7: 369-75.
    • (1997) Thyroid , vol.7 , pp. 369-375
    • Vitti, P.1    Rago, T.2    Chiovato, L.3
  • 17
    • 1642366061 scopus 로고    scopus 로고
    • Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease
    • Schott M, Morgenthaler MG, Fritzen R, et al. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease. Horm Metab Res 2004, 36: 92-6.
    • (2004) Horm Metab Res , vol.36 , pp. 92-96
    • Schott, M.1    Morgenthaler, M.G.2    Fritzen, R.3
  • 18
    • 34548703115 scopus 로고    scopus 로고
    • Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission
    • Eckstein AK, Lax H, Lösch C, et al. Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission. Clin Endocrinol (Oxf) 2007, 67: 607-12.
    • (2007) Clin Endocrinol (Oxf) , vol.67 , pp. 607-612
    • Eckstein, A.K.1    Lax, H.2    Lösch, C.3
  • 19
    • 26944493835 scopus 로고    scopus 로고
    • Bartalena L. Graves' ophthalmopathy: search for shared autoantigen(s) continues. J Endocrinol Invest 2005, 28: 396-7.
    • Bartalena L. Graves' ophthalmopathy: search for shared autoantigen(s) continues. J Endocrinol Invest 2005, 28: 396-7.
  • 20
    • 0033386948 scopus 로고    scopus 로고
    • The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy
    • Khoo DHC, Ho SC, Seah LL, et al. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy. Thyroid 1999, 9: 1175-80.
    • (1999) Thyroid , vol.9 , pp. 1175-1180
    • Khoo, D.H.C.1    Ho, S.C.2    Seah, L.L.3
  • 21
    • 33748740658 scopus 로고    scopus 로고
    • Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease
    • Eckstein AK, Plicht M, Lax H, et al. Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 2006, 91: 3464-70.
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 3464-3470
    • Eckstein, A.K.1    Plicht, M.2    Lax, H.3
  • 23
    • 0026695590 scopus 로고
    • Relationsnip between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism
    • Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Pinchera A. Relationsnip between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism. Thyroid 1992, 2: 171-8.
    • (1992) Thyroid , vol.2 , pp. 171-178
    • Marcocci, C.1    Bartalena, L.2    Bogazzi, F.3    Bruno-Bossio, G.4    Pinchera, A.5
  • 24
    • 10744231097 scopus 로고    scopus 로고
    • Effects of thyroidectomy alone or followed by radioiodine ablation of thyroid remnants on the outcome of Graves' ophthalmopathy
    • Moleti M, Mattina F, Salamone I, et al. Effects of thyroidectomy alone or followed by radioiodine ablation of thyroid remnants on the outcome of Graves' ophthalmopathy. Thyroid 2003, 13: 653-8.
    • (2003) Thyroid , vol.13 , pp. 653-658
    • Moleti, M.1    Mattina, F.2    Salamone, I.3
  • 25
    • 34249861894 scopus 로고    scopus 로고
    • Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids
    • Menconi F, Marinò M, Pinchera A, et al. Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids. J Clin Endocrinol Metab 2007, 92: 1653-8.
    • (2007) J Clin Endocrinol Metab , vol.92 , pp. 1653-1658
    • Menconi, F.1    Marinò, M.2    Pinchera, A.3
  • 26
    • 1642453721 scopus 로고    scopus 로고
    • Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens
    • Chiovato L, Latrofa F, Braverman LE, et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 2003, 139: 346-51.
    • (2003) Ann Intern Med , vol.139 , pp. 346-351
    • Chiovato, L.1    Latrofa, F.2    Braverman, L.E.3
  • 27
    • 0032495566 scopus 로고    scopus 로고
    • Preventing Graves' ophthalmopathy
    • Wiersinga WM. Preventing Graves' ophthalmopathy. N Engl J Med 1998, 338: 121-2.
    • (1998) N Engl J Med , vol.338 , pp. 121-122
    • Wiersinga, W.M.1
  • 28
    • 0032495543 scopus 로고    scopus 로고
    • Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy
    • Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998, 338: 73-8.
    • (1998) N Engl J Med , vol.338 , pp. 73-78
    • Bartalena, L.1    Marcocci, C.2    Bogazzi, F.3
  • 29
    • 40949088519 scopus 로고    scopus 로고
    • Consensus statement of the European Group on Graves' Orbitopathy (EUGOGO) on management of Graves' Orbitopathy
    • Bartalena L, Baldeschi L, Dickinson AJ, et al. Consensus statement of the European Group on Graves' Orbitopathy (EUGOGO) on management of Graves' Orbitopathy. Thyroid 2008, 18: 333-46.
    • (2008) Thyroid , vol.18 , pp. 333-346
    • Bartalena, L.1    Baldeschi, L.2    Dickinson, A.J.3
  • 30
    • 40949140917 scopus 로고    scopus 로고
    • Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
    • Bartalena L, Baldeschi L, Dickinson AJ, et al. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 2008, 158: 273-85.
    • (2008) Eur J Endocrinol , vol.158 , pp. 273-285
    • Bartalena, L.1    Baldeschi, L.2    Dickinson, A.J.3
  • 31
    • 0031757262 scopus 로고    scopus 로고
    • Ablative or non-ablative therapy for Graves' hyperthyroidism in patients with ophthalmopathy?
    • Marcocci C, Bartalena L, Pinchera A. Ablative or non-ablative therapy for Graves' hyperthyroidism in patients with ophthalmopathy? J Endocrinol Invest 1998, 21: 468-71.
    • (1998) J Endocrinol Invest , vol.21 , pp. 468-471
    • Marcocci, C.1    Bartalena, L.2    Pinchera, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.